Holen Sie sich die Stockscreener-App
2.89
2.85%
0.08
Handel nachbörslich:
2.92
0.03
+1.04%
Schlusskurs vom Vortag:
$2.81
Offen:
$2.88
24-Stunden-Volumen:
967.03K
Relative Volume:
1.43
Marktkapitalisierung:
$215.42M
Einnahmen:
$405.47M
Nettoeinkommen (Verlust:
$53.66M
KGV:
4.0139
EPS:
0.72
Netto-Cashflow:
$131.28M
1W Leistung:
+0.35%
1M Leistung:
+3.21%
6M Leistung:
-26.09%
1J Leistung:
-40.29%
1-Tages-Spanne:
$2.85
$2.955
1-Wochen-Bereich:
$2.795
$3.015
52-Wochen-Spanne:
$2.36
$4.92
Orasure Technologies Inc Stock (OSUR) Company Profile
Firmenname
Orasure Technologies Inc
Sektor
Telefon
(503) 641-6115
Adresse
220 E FIRST ST, BETHLEHEM, PA
Vergleichen Sie OSUR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
2.89 | 215.42M | 405.47M | 53.66M | 131.28M | 0.72 |
|
ISRG
Intuitive Surgical Inc
|
557.08 | 197.97B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
173.45 | 49.82B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.79 | 42.51B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
252.20 | 35.89B | 5.02B | 1.31B | 1.56B | 8.91 |
|
BAX
Baxter International Inc
|
30.26 | 15.65B | 11.89B | -560.00M | 191.00M | -1.10 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-03 | Fortgesetzt | Evercore ISI | In-line |
| 2021-09-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | Eingeleitet | Evercore ISI | Outperform |
| 2020-08-10 | Eingeleitet | Citigroup | Buy |
| 2020-08-10 | Eingeleitet | JP Morgan | Neutral |
| 2020-08-07 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | Eingeleitet | Lake Street | Buy |
| 2020-04-21 | Fortgesetzt | Stephens | Equal-Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Mkt Perform |
| 2018-07-16 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | Herabstufung | Jefferies | Buy → Hold |
| 2017-02-09 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | Bestätigt | Mizuho | Buy |
| 2015-05-07 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | Bestätigt | Mizuho | Buy |
| 2014-06-12 | Bestätigt | Canaccord Genuity | Buy |
| 2014-06-11 | Bestätigt | Mizuho | Buy |
| 2012-12-21 | Eingeleitet | Mizuho | Buy |
| 2012-08-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | Eingeleitet | JMP Securities | Mkt Outperform |
Alle ansehen
Orasure Technologies Inc Aktie (OSUR) Neueste Nachrichten
Top Penny Stocks To Watch In May 2025 - simplywall.st
OraSure Technologies: Multiple Shots To Deliver Value (NASDAQ:OSUR) - Seeking Alpha
Orasure Technologies Inc Files For Mixed Shelf Of Up To $300 MillionSEC Filing - marketscreener.com
OraSure (OSUR) Files for $300 Million Mixed Securities Offering - GuruFocus
Evercore says 23andMe buyout removes downside case for OraSure - Yahoo Finance
OraSure Technologies (NASDAQ:OSUR) Receives “In-Line” Rating from Evercore ISI - Defense World
Jane Street Group LLC Has $1.47 Million Stock Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure rises as seen benefitting from 23andMe/Regeneron deal - MSN
OraSure Technologies (OSUR) Rises on Regeneron-23andMe Deal - GuruFocus
OraSure stock rises following Regeneron’s 23andMe acquisition - Investing.com
OraSure Technologies (OSUR) Maintains In-Line Rating with Everco - GuruFocus
Hold Rating on Orasure Technologies Amid 23andMe Acquisition and Revenue Uncertainties - TipRanks
OraSure (OSUR) Sees Positive Outlook with 23andMe Partnership | - GuruFocus
OraSure Technologies (OSUR) Sees Positive Market Reaction | OSUR Stock News - GuruFocus
OraSure (OSUR) Sees Positive Outlook with 23andMe Partnership | OSUR Stock News - GuruFocus
OraSure’s Board of Directors has a new Member Stephen S. Tang, Ph.D., has joined OraSure T - Medical Product Outsourcing
OraSure Technologies (NASDAQ:OSUR) Raised to Hold at StockNews.com - Defense World
Tower Research Capital LLC TRC Grows Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Targeted Genomics, OraSure in pact for at-home celiac genetic testing - MSN
10,227 Shares in OraSure Technologies, Inc. (NASDAQ:OSUR) Bought by Raymond James Financial Inc. - Defense World
Voya Investment Management LLC Sells 28,998 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure Technologies Approves Stock Plan Amendment at Annual Meeting - TipRanks
OraSure, Targeted Genomics in pact for at-home celiac genetic testing - Seeking Alpha
OraSure Technologies (OSUR) Partners to Enhance At-Home Celiac T - GuruFocus
Targeted Genomics Announces Commercial Collaboration with - GlobeNewswire
Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing - The Manila Times
OraSure Technologies (NASDAQ:OSUR) Cut to Sell at StockNews.com - Defense World
Orasure technologies outlines Q2 2025 revenue guidance of $28.5M-$32.5M amid new product launches and customer expansions - MSN
OraSure Executive Resigns, Effective June 30 - Investing.com
OraSure Executive Resigns, Effective June 30 By Investing.com - Investing.com India
OraSure Technologies First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
OraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2025 Earnings Call Transcript - Insider Monkey
OraSure Technologies Announces CPO Resignation - TipRanks
Orasure Technologies, Inc. Announces Resignation of Chief Product Officer Kathleen G. Weber Effective June 30, 2025 - marketscreener.com
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Sold by Envestnet Asset Management Inc. - Defense World
Evercore ISI cuts OraSure stock price target to $3 from $4 - Investing.com Nigeria
Shareholders Will Probably Hold Off On Increasing OraSure Technologies, Inc.'s (NASDAQ:OSUR) CEO Compensation For The Time Being - simplywall.st
Earnings call transcript: OraSure’s Q1 2025 beats EPS forecast, stock stable - Investing.com Nigeria
OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth - GuruFocus
OraSure Technologies Reports Q1 2025 Financial Results - TipRanks
OraSure: Q1 Earnings Snapshot - The Washington Post
OraSure reports first quarter loss, but looks forward to emerging as 'stronger enterprise' - WFMZ.com
OraSure Technologies (OSUR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
OraSure (OSUR) Reports Q1 Revenue Slightly Above Expectations | OSUR Stock News - GuruFocus
OraSure Technologies (OSUR) Projects Q2 2025 Revenue Growth | OS - GuruFocus
OraSure Technologies Reports Q1 2025 Revenue Decline - TipRanks
OraSure Technologies (OSUR) Projects Q2 2025 Revenue Growth | OSUR Stock News - GuruFocus
Finanzdaten der Orasure Technologies Inc-Aktie (OSUR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.70%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):